Published in Am J Med on December 01, 1947
Awareness of the role of atrial fibrillation as a cause of ischemic stroke. Stroke (2013) 0.75
Re-opening the case of the abdominal aortic aneurysm. Circulation (1956) 2.33
Long-term anticoagulant therapy; further experiences. Circulation (1954) 1.67
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia. J Am Med Assoc (1951) 1.53
Thrombophlebitis and cancer. JAMA (1961) 1.48
The pathogenesis and treatment of thrombosis. Circulation (1952) 1.47
Carotid artery occlusive syndrome. Arch Neurol (1959) 1.29
The use of anticoagulants for thrombophlebitis during pregnancy. Am J Obstet Gynecol (1959) 1.23
The treatment of cerebral thrombosis and embolism with anticoagulant drugs; preliminary observations. Med Clin North Am (1950) 1.22
The electrical conductivity of blood. II. Relation to red cell count. Blood (1950) 1.20
Treatment of gangrene of the feet and legs by walking. Circulation (1957) 1.18
Cerebral vascular diseases: their significance, diagnosis, and present treatment, including the selective use of anticoagulant substances. Lancet (1954) 1.16
A long-term study of cerebral vascular disease. Ann Intern Med (1961) 1.11
Cerebral vascular diseases: their significance, diagnosis and present treatment, including the selective use of anticoagulant substances. Ann Intern Med (1954) 1.05
Myocardial infarction and its treatment with anticoagulants: a summary of the findings for 1031 cases. Mod Concepts Cardiovasc Dis (1954) 1.02
Failure of ingestion of cream to affect blood coagulation. Am J Med (1953) 1.02
Present status of anticoagulant treatment of cerebral vascular lesions. Med Clin North Am (1958) 1.00
Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulant therapy. Am J Med (1958) 0.99
An evaluation of anticoagulant therapy. Am J Med (1953) 0.99
Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties. Circulation (1951) 0.99
Use of anticoagulants in treatment of cerebral vascular disease; ten-year experience in treatment of thromboembolism. J Am Med Assoc (1958) 0.98
The effect of phosphorylated hesperidin on the polymerization of fibrinogen as studied by light scattering. J Biol Chem (1955) 0.96
A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association. Circulation (1952) 0.96
The pathogenesis, diagnosis and treatment of strokes: a progress report. Ann Intern Med (1958) 0.95
Studies with crystalline trypsin: results and hazards of intravenous administration and its postulated role in blood coagulation. J Am Med Assoc (1954) 0.94
Early use of anticoagulants in treatment of myocardial infarction. J Am Med Assoc (1957) 0.92
The modern treatment of coronary thrombosis with myocardial infarction. Circulation (1950) 0.92
Further experience with long-term anticoagulant therapy. AMA Arch Intern Med (1955) 0.92
Intracranial lesions simulating cerebral thrombosis. J Am Med Assoc (1960) 0.91
Dental surgery during continuous anticoagulant therapy. JAMA (1961) 0.90
The effect of intravenous trypsin administration on the electrocardiogram of the rabbit. Circulation (1954) 0.89
Use of different tissue thromboplastins in the control of anticoagulant therapy. Circulation (1957) 0.89
A cooperative study of cerebrovascular disease; methodology and a preliminary report on the use of anticoagulants. Circulation (1959) 0.89
The electrical conductivity of blood. I: Relationship to erythrocyte concentration. Blood (1950) 0.88
Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant. Circulation (1954) 0.88
STROKES--DIAGNOSIS AND MODERN TREATMENT. (I). Mod Concepts Cardiovasc Dis (1965) 0.88
A synthetic anticoagulant: a polysulfuric acid ester of polyanhydromannuronic acid (paritol); experience with its use in man. Circulation (1950) 0.84
Further experiences with blood coagulation after fat meals and carbohydrate meals. Circulation (1958) 0.84
Problems of anticoagulant therapy in cerebrovascular disease. Neurology (1959) 0.84
Bedside diagnosis of carotid-artery occlusive disease. N Engl J Med (1960) 0.84
Thromboembolic complications following so-called good risk cases of myocardial infarction. Circulation (1956) 0.84
The treatment of occlusive arterial disease. Viewpoint of an internist. JAMA (1963) 0.84
Effects of vitamin E preparations on plasma tocopherol levels. J Clin Nutr (1954) 0.84
Effect of safflower oil emulsion on serum cholesterol levels in young adult males; its use as a supplement to a normal diet. J Am Med Assoc (1958) 0.83
The use of anticoagulants; an evaluation. Med Clin North Am (1956) 0.83
Deficiency of one or more factors of unusual interest. Thromb Diath Haemorrh (1960) 0.82
Ineffectiveness of heparin by sublingual administration. J Am Med Assoc (1952) 0.82
Long-term anticoagulant therapy. Circulation (1954) 0.81
Strokes; diagnosis and modern treatment. II. Treatment. Mod Concepts Cardiovasc Dis (1959) 0.81
Electrokinetic studies on fibrinogen. III. The effect of concentration, pH, and surface on the fibrinogen-solid interfacial potential. Arch Biochem Biophys (1954) 0.80
Evaluation of prothrombin times performed with different thromboplastins. Acta Med Scand (1959) 0.80
SUBCLAVIAN STEAL SYNDROME WITH OLFACTORY HALLUCINATIONS. Ann Intern Med (1964) 0.80
The use of anticoagulants in coronary heart disease. Progress and problems: 1960. Circulation (1960) 0.80
The nomenclature of blood clotting factors. Can Med Assoc J (1962) 0.79
Present status of anticoagulant therapy in the treatment of myocardial infarction; the use and misuse of anticoagulants; an evaluation of new anticoagulants, their indications and dosage. Ann Intern Med (1955) 0.78
Cerebrovascular disease with aging; transcription of a panel meeting. Bull N Y Acad Med (1956) 0.77
The pathogenesis, prevention and medical management of peripheral arterial thrombosis. Am J Med (1957) 0.77
SHIP-TO-SHORE RADIO TRANSMISSION OF ELECTROCARDIOGRAMS AND X-RAY IMAGES. JAMA (1965) 0.77
Experiences with dicumarol (3,3' methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction; preliminary report. Am Heart J (1946) 0.76
A new blood clotting inhibitor. J Biol Chem (1948) 0.76
Concerning the functions and nomenclature of blood clotting factors, with a preliminary report of the profile of blood clotting factors in young males. Ann Intern Med (1959) 0.76
The nomenclature of blood clotting factors. Thromb Diath Haemorrh (1962) 0.76
Dental surgery during continuous anticoagulant therapy. J Am Dent Assoc (1961) 0.75
Nomenclature of blood clotting factors; acceptance by the International Committee on nomenclature of four factors, their characteristics and international number. Can Med Assoc J (1958) 0.75
Experience with anticoagulants. Circulation (1959) 0.75
THE SUBCLAVIAN STEAL AND OTHER SHOULDER GIRDLE SYNDROMES. Trans Am Clin Climatol Assoc (1964) 0.75
Reopening the case of the abdominal aortic aneurysm. Trans Am Clin Climatol Assoc (1957) 0.75
Some reasons for failure when using dicumarol for the prevention and treatment of thromboembolic complications following coronary thrombosis with myocardial infarction. Stanford Med Bull (1948) 0.75
[Nomenclature of blood coagulation factors. Recognition, characterization and international numbering of 4 blood coagulation factors (V, VII, VIII, IX) by the International Committee for the Nomenclature of Blood Coagulation Factors]. Dtsch Med Wochenschr (1959) 0.75
[Nomenclarure of blood coagulation factors; characterization & numbering of 4 factors by the international committee on nomenclature]. Nord Med (1959) 0.75
[Nomenclature of coagulation factors. Acceptance of 4 factors by the International Committee on Nomenclature: their characterization and international number]. Haematologica (1959) 0.75
Treatment of thromboembolic diseases. Criteria for evaluation of studies. JAMA (1960) 0.75
The diagnosis and treatment of occlusive cerebral vascular disease. N Y State J Med (1960) 0.75
Dicumarol, coumadin, marcumar and tromexan; comparative study of their action on the clot as registered by the thrombelastogram. Circulation (1959) 0.75
Anticoagulant therapy of coronary thrombosis with myocardial infarction. J Am Med Assoc (1948) 0.75
Cerebral thromboembolism. Bibl Cardiol (1958) 0.75
Strokes; diagnosis and modern treatment. I. Diagnosis. Mod Concepts Cardiovasc Dis (1959) 0.75
Safflower oil-pyridoxine and corn oilpyridoxine emulsions; their effect on serum cholesterol levels in young adult males when used as supplements to a normal diet. J Am Med Assoc (1959) 0.75
Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction. J Mich State Med Soc (1948) 0.75
A profile of cerebral vascular accidents today. GP (1959) 0.75
[The value of thromboelastography in the diagnosis of thrombophlebitis]. Arch Inst Cardiol Mex (1960) 0.75
From the atom to the patient. J Am Med Assoc (1959) 0.75
Anticoagulation therapy today. Med Clin North Am (1961) 0.75
Coronary artery disease: progress and problems. J Am Geriatr Soc (1960) 0.75
Anticoagulant therapy in coronary thrombosis and rheumatic heart diseases with thrombo-embolic complications. Cinci J Med (1948) 0.75
Recent trends in therapy of cerebral vascular disease. Circulation (1961) 0.75
Strokes; the present status of diagnosis and treatment. Postgrad Med (1959) 0.75
[Terminology of blood clotting factors]. Harefuah (1960) 0.75
Health of repatriated prisoners of war from the Far East. J Am Med Assoc (1946) 0.75
[Nomenclature of blood coagulation factors. Acknowledgement by the International Committee for Nomenclature of 4 factors with their characterization and internationally accepted number]. Belg Tijdschr Geneesk (1959) 0.75
The discovery and early development of anticoagulants: a historical symposium. Circulation (1959) 0.75
The status of long-term anticoagulant therapy for coronary heart disease. Prog Cardiovasc Dis (1960) 0.75
The use of anticoagulants in the treatment of diseases of the heart and blood vessels (summary). Bull Chic Med Soc (1947) 0.75
Use of different tissue thromboplastins in the control of anticoagulant-therapy. Thromb Diath Haemorrh (1958) 0.75